Antithrombotic therapy in heart failure

Netherlands Heart Journal

Volumn 20, Issue 4, 2012, Pages 176-178

  Verheugt, F W A ^a  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

Author keywords

Aspirin; Clopidogrel; Heart failure; Stroke; Thromboembolism; Warfarin

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PROSTAGLANDIN; WARFARIN;

BLEEDING; BRAIN HEMORRHAGE; CONGESTIVE HEART FAILURE; DEATH; HEART FAILURE; HEART INFARCTION; HUMAN; PROPHYLAXIS; REVIEW; RISK; SINUS RHYTHM; STROKE; THROMBOEMBOLISM;

EID: 84859645375     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-012-0250-5     Document Type: Review

References (6)

1. Loh E, St John Sutton M, Wun CC, et al. Ventricular dysfunction and the risk of stroke after myocardial infarction. N Engl J Med. 1997;336:251-7.
2. Teo KK, Yusuf S, Pfeffer M, et al. Effects of long-term treatment with angiotensin-converting enzyme inhibitors in the presence or absence of aspirin: a systematic review. Lancet. 2002;360:1037-43.
3. Massie BM, Krol WF, Ammon SE, et al. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. J Card Fail. 2004;10:101-12.
4. Massie BM, Collins JF, Ammon SE, et al. Randomized trial of warfarin, aspirin and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Heart Failure (WATCH) Trial. Circulation. 2009;119:1616-24.
5. Cleland JGF, Findlay I, Jafri S, et al. The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies in patients with heart failure. Am Heart J. 2004;148:157-64.
6. Masoudi FA, Wolfe P. Havranek, et al. Aspirin use in older patients with heart failure and coronary artery disease: national prescription patterns and relationship with outcomes. J Am Coll Cardiol. 2005;46:955-62.